PROCEPT BioRobotics Q2 2026 Revenue Rises 19% To $94.5M
PROCEPT BioRobotics reported strong Q2 2026 financial results with 19% revenue growth due to robust HYDROS placements and pricing discipline, increasing gross margin to 66%.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day